3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
36
Leukemia
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Gastrointestinal Stromal Tumors
13
Leukemia, Myeloid, Chronic-Phase
12
Leukemia, Myeloid
6
Brain Neoplasms
6
Prostatic Neoplasms
5
Philadelphia Chromosome
5
Blast Crisis
5
Sarcoma
4
Recurrence
4
Glioblastoma
4
Carcinoma, Non-Small-Cell Lung
4
Bone Marrow Diseases
4
Ovarian Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Hematologic Diseases
3
Bronchiolitis Obliterans Syndrome
3
Breast Neoplasms
3
Stomach Neoplasms
2
Polycythemia Vera
2
Neurofibromatoses
2
Neoplasms by Histologic Type
2
Neoplasms
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Meningioma
2
Interventions
Mycophenolic Acid
3
Cyclosporine
3
midostaurin
2
fludarabine phosphate
2
Whole-Body Irradiation
2
Therapeutics
2
Peripheral Blood Stem Cell Transplantation
2
Darbepoetin alfa
2
thymoglobulin
1
ibrutinib
1
hydrocortisone valerate
1
ferrous sulfate
1
ferric gluconate
1
avapritinib
1
Sunitinib
1
Sucrose
1
Rituximab
1
Oxycodone
1
Morphine
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone Acetate
1
Methylprednisolone
1
Methadone
1
Hydrocortisone
1
Granulocyte Colony-Stimulating Factor
1
Granisetron
1
Filgrastim
1
Epoetin Alfa
1
Enzyme-Linked Immunosorbent Assay
1
Early Intervention, Educational
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Mast-Cell
×
Imatinib Mesylate
×
Clear all
No trials found.